Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia. 2009

Sheeja T Pullarkat, and Vinod Pullarkat, and Steven H Kroft, and Carla S Wilson, and Arshad N Ahsanuddin, and Karen P Mann, and Maung Thein, and Wayne W Grody, and Russell K Brynes
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, CHS, A7-149, Los Angeles, CA, 90095-1732, USA, spullarkat@mednet.ucla.edu.

Although KIT mutations are present in 20-25% of cases of t(8;21)(q22;q22) acute myeloid leukemia (AML), concurrent development of systemic mastocytosis (SM) is exceedingly rare. We examined the clinicopathologic features of SM associated with t(8;21)(q22;q22) AML in ten patients (six from our institutions and four from published literature) with t(8;21) AML and SM. In the majority of these cases, a definitive diagnosis of SM was made after chemotherapy, when the mast cell infiltrates were prominent. Deletion 9q was an additional cytogenetic abnormality in four cases. Four of the ten patients failed to achieve remission after standard chemotherapy and seven of the ten patients have died of AML. In the two patients who achieved durable remission after allogeneic hematopoietic stem cell transplant, recipient-derived neoplastic bone marrow mast cells persisted despite leukemic remission. SM associated with t(8;21) AML carries a dismal prognosis; therefore, detection of concurrent SM at diagnosis of t(8;21) AML has important prognostic implications.

UI MeSH Term Description Entries

Related Publications

Sheeja T Pullarkat, and Vinod Pullarkat, and Steven H Kroft, and Carla S Wilson, and Arshad N Ahsanuddin, and Karen P Mann, and Maung Thein, and Wayne W Grody, and Russell K Brynes
May 2021, Blood,
Sheeja T Pullarkat, and Vinod Pullarkat, and Steven H Kroft, and Carla S Wilson, and Arshad N Ahsanuddin, and Karen P Mann, and Maung Thein, and Wayne W Grody, and Russell K Brynes
October 2013, American journal of clinical pathology,
Sheeja T Pullarkat, and Vinod Pullarkat, and Steven H Kroft, and Carla S Wilson, and Arshad N Ahsanuddin, and Karen P Mann, and Maung Thein, and Wayne W Grody, and Russell K Brynes
January 2012, Indian journal of pathology & microbiology,
Sheeja T Pullarkat, and Vinod Pullarkat, and Steven H Kroft, and Carla S Wilson, and Arshad N Ahsanuddin, and Karen P Mann, and Maung Thein, and Wayne W Grody, and Russell K Brynes
January 2016, Indian journal of pathology & microbiology,
Sheeja T Pullarkat, and Vinod Pullarkat, and Steven H Kroft, and Carla S Wilson, and Arshad N Ahsanuddin, and Karen P Mann, and Maung Thein, and Wayne W Grody, and Russell K Brynes
October 2011, Pediatric blood & cancer,
Sheeja T Pullarkat, and Vinod Pullarkat, and Steven H Kroft, and Carla S Wilson, and Arshad N Ahsanuddin, and Karen P Mann, and Maung Thein, and Wayne W Grody, and Russell K Brynes
January 2014, Terapevticheskii arkhiv,
Sheeja T Pullarkat, and Vinod Pullarkat, and Steven H Kroft, and Carla S Wilson, and Arshad N Ahsanuddin, and Karen P Mann, and Maung Thein, and Wayne W Grody, and Russell K Brynes
November 2017, Annals of clinical and laboratory science,
Sheeja T Pullarkat, and Vinod Pullarkat, and Steven H Kroft, and Carla S Wilson, and Arshad N Ahsanuddin, and Karen P Mann, and Maung Thein, and Wayne W Grody, and Russell K Brynes
March 1994, Cancer genetics and cytogenetics,
Sheeja T Pullarkat, and Vinod Pullarkat, and Steven H Kroft, and Carla S Wilson, and Arshad N Ahsanuddin, and Karen P Mann, and Maung Thein, and Wayne W Grody, and Russell K Brynes
March 2008, International journal of hematology,
Sheeja T Pullarkat, and Vinod Pullarkat, and Steven H Kroft, and Carla S Wilson, and Arshad N Ahsanuddin, and Karen P Mann, and Maung Thein, and Wayne W Grody, and Russell K Brynes
August 2009, British journal of haematology,
Copied contents to your clipboard!